Perspective argues for integrating community-based adulteration reporting into drug early warning systems, suggesting enhanced surveillance.
Drug checking services cover only a minority of people who use drugs. This perspective argues that digital community-based adulteration reporting platforms, crowdsourced, anonymous, real-time systems collecting user- and professional-generated reports of suspected adulteration, constitute a complementary surveillance layer that should be formally integrated with the EUDA Early Warning System and national equivalents. Four complementarities between chemical-analysis services and community reporting are identified (epistemic, temporal, coverage, infrastructural), four implementation principles are proposed, and three objections are examined. Three concrete policy steps are outlined: a reference data model under EUDA coordination, formal recognition of community reporting as preliminary evidence within the EWS, and pilot integration workflows in member states with mature drug checking architectures.
No takes yet. Share an insight, caveat, or question.
Alexandre DELFORGE (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: